Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children – PHARMACOLOGICAL RESEARCH

Zapata-Cobo, P; Salvador-Martín, S; Velasco, M; Palomino, LM; Clemente, S; Segarra, O; Moreno-Alvarez, A; Fernandez-Lorenzo, A; Pérez-Moneo, B; Montraveta, M; Sanchez, C; Tolin, M; Loverdos, I; Fobelo, MJ; Navas-López, VM; Magallares, L; García-Romero, R; Sánchez-Hernández, JG; Rodríguez, A; Bossacoma, F; Balboa, MJ; Salcedo, E; Sanjurjo-Sáez, M; López-Fernández, LA – 2023 – 10.1016/j.phrs.2023.106859